Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

Stem Cells & Perinatal Therapies

Cell and perinatal products: promise, evidence, quality and clinical limitations.

Interactive cases & learning

A selection of published cases and interactive modules is shown below. Open the section title to browse the full directory.

Rheumatology in Perspective

Library

Search by topic, condition or question

29 materials

Clear filters

Interactive · Autoinflammatory conditions

Read the Report

Variants, specimens, thresholds and criteria in autoinflammatory disease: seven rounds on what a result can — and cannot — tell you.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Interactive · Autoinflammatory conditions

When the Tempo Changes

Fast emergencies and slow ones: MAS, HLH and AA amyloidosis across the autoinflammatory syndromes — read the direction, not the reference range.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Interactive · Autoinflammatory conditions

Label, Dose, Interaction

Colchicine, IL-1, IL-6 and interferon-γ blockade across the autoinflammatory syndromes: what the label says, what the dose is and what must not be combined.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Interactive · Autoinflammatory conditions

Not Every Fever Is Ours

Mimics, neighbours and diagnostic shortcuts: seven rounds on what has to be excluded before — and after — the word “autoinflammatory”.

ProfessionalsEN · RU · ES · PLOpen demo

Reviewed

Interactive · Autoinflammatory conditions

The Pattern Has a Name

Seven rounds on telling one autoinflammatory syndrome from another — by the attack, the organ and the clue that does not fit.

ProfessionalsEN · RU · ES · PLOpen demo

Reviewed

Case & Reasoning · Autoinflammatory conditions

Transfer Is Not Transition

A referral letter is an event; continuity is the outcome.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Case & Reasoning · Autoinflammatory conditions

Quiet Attacks, Loud Kidneys

A good month for symptoms can still be a bad year for the kidney.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Case & Reasoning · Autoinflammatory conditions

Same Label, New Organs

An undifferentiated diagnosis should stay honest about what it does not know.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Case & Reasoning · Autoinflammatory conditions

The Injections Are Working

Fever and rash are gone. The IgM is still there.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Case & Reasoning · Autoinflammatory conditions

One Response, Two Diseases

In VEXAS, a better CRP is not a better marrow.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Case & Reasoning · Autoinflammatory conditions

Normal Is Not Reassuring

In MAS, the direction of a number matters more than its range.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Case & Reasoning · Autoinflammatory conditions

Day 7, Week 4, Month 3

Still’s disease has a calendar — and a few traps along the way.

ProfessionalsEN · RU · ES · PLProfessional access

Reviewed

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: Medical educationPatient educationRheumatology